Clinical Trial Update: Atropine in the Treatment of Myopia Study in Malaysia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Malaysia evaluating atropine for slowing myopia progression is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Atropine sulfate (generic) (atropine sulfate)

Snippet

Sponsor: IDB VisionCare SDN BHD | Conditions: Myopia Progression | Phase 3 | Status: RECRUITING